FDA approves a second PSMA targeting agent for PET imaging in men with prostate cancer. . BJU Int 2021;128:127-130.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. FDA approves a second PSMA targeting agent for PET imaging in men with prostate cancer. BJU Int 2021;128:127-130.
PMID: 34318983